1.Coefficient Variations of Serum Levels of Phenytoin, Carbamazepine, and Valproic Acid in Compliant Epileptics.
Hae Jung YUN ; O Y KWON ; K J PARK ; N G KIM ; T Y KIM ; S C JEON ; J G HONG ; J H KWAK ; Y H LEE ; N C CHOI ; B H LIM
Journal of the Korean Neurological Association 1999;17(1):72-78
Compliance of epileptic patients is one of the most important factors for adequate therapy. Recently, it had been shown that the variability of three serial measurement of the serum levels of antiepileptic drug(AED) may be used as an indication of the degree of compliance. Coefficient variation(CV) of serum drug levels calculated by only one AED had been used to determine the compliance in epileptic patients who took multiple AEDs. We attempted to evaluate the CV of AEDs and then find the objective clue of compliance and the compatible therapeutic planing according to CV. Ninety seven epileptic patients of outpatients department of the Gyengsang National University Hospital were entered to this study. All patients were taking medication at least for 6 months without any changes of drug regimen. Patient's information was acquired by reviewing the chart and interview with questionnaire. With these informations, we determined the compliance of the patients. Antiepileptic serum levels were measured three times at intervals of at least two to four weeks apart, and their CV was calculated. We compared the CV between the compliant and non-compliant group in each AED(phenytoin, carbamazepine , valproic acid) and three drugs in the compliant group. The mean CVs of phenytoin, carbamazepine and valproic acid in the compliant group were 18.3+/-13.0, 15.2+/-10.2 and 23.8+/-8.9, respectively(mean+/-SD). The mean of CV in the compliant and the non-compliant group were 17.9+/-10.9 and 38.8+/-27.2, respectively. The CVs of the compliant group were significantly lower than those of the non-compliant group(p<0.05). However, CVs had no significant difference between three antiepileptic drugs. This study showed that CVs of AEDs were not different between each AEDs, even though they possess different pharmacokinetic properties. Therefore, the CV of one AED can be used in determining the compliance of the epileptics who are taking multiple AEDs.
Anticonvulsants
;
Carbamazepine*
;
Compliance
;
Humans
;
Outpatients
;
Phenytoin*
;
Surveys and Questionnaires
;
Valproic Acid*
2.Clinical Features and Prognostic Factors in Primary Adenocarcinoma of the Appendix.
In J PARK ; Chang S YU ; Hee C KIM ; Jin C KIM
The Korean Journal of Gastroenterology 2004;43(1):29-34
BACKGROUND/AIMS: Primary appendiceal adenocarcinoma is a rare neoplasm that constitutes less than 0.5% of all gastrointestinal neoplasm. The aim of this study was to figure out its clinicopathologic characteristics that are not well understood. METHODS: We reviewed the medical records of nineteen patients (9 males and 10 females) with histologically proven appendiceal adenocarcinoma. They had been treated at Asan Medical Center between June 1989 and December 2002. Their median follow-up duration was 72.5 months. RESULTS: Their median age was 56.5 (range, 33~80) years. Thirteen patients had mucinous variants and the other five had adenocarcinoma. Seven patients (36.8%) were diagnosed as acute appendicitis. In fact, none of the patients was diagnosed correctly before surgery. The operative procedure, included right hemicolectomy in 9 patients, appendectomy alone in 2 patients, and debulking of their tumors or a biopsy in 8 patients. The 5-year survival rate was 20.5%. The patients with mucinous type had better prognosis than those with the non-mucinous type (p<0.01). In the patients with mucinous type, the survival rate after debulking operation was similar to that after right hemicolectomy. CONCLUSIONS: The most important prognostic factor of primary appendiceal adenocarcinoma was histology. The outcome of debulking operation is being watched compared with that of right hemicolectomy in mucinous variant.
Adenocarcinoma/*diagnosis/mortality/surgery
;
Adult
;
Aged
;
Appendiceal Neoplasms/*diagnosis/mortality/surgery
;
English Abstract
;
Female
;
Humans
;
Male
;
Middle Aged
;
Prognosis
;
Survival Rate
3.A Clinical Study of Topical Minoxidil Therapy in Alopecia: Multicenter Trials.
Min Geol LEE ; Moon Soo YOON ; Jung Bock LEE ; Byung In RO ; Hyung Ok KIM ; Kyung Jae CHUNG ; Choong Rim HAW ; Kyu Suk LEE ; S N KIM ; S J SON ; J A KIM ; H J KIM ; H I KOOK ; H S SUNG ; Y P KIM ; C W IHM ; J K PARK ; K J KIM ; J H KIM
Korean Journal of Dermatology 1986;24(2):181-189
No abstract available.
Alopecia*
;
Minoxidil*
4.The Usefulness of Fetal Fibronectin as a Diagnostic Method of Preterm Ruptere of Membrane.
Chan Woo PARK ; Tae Sook YOON ; Ji Young LEE ; C J PARK ; Yoo Kon KIM ; Bong Rim JANG ; Yang Seo PARK
Korean Journal of Perinatology 1997;8(3):291-294
OBJECTIVE: The purpose of this study was to evaluate the fetal fibronectin as a diagnostic method of preterm rupture of membanes and its clinical usefulness compared with standard tests. STUDY DESIGN: Seventy-eight women who had recieved antenatal care and complained of fluid leakage prior to 37 weeks were enrolled in this study. Standard tests-vaginal peculum examination, Nitrazine test, transabdominal sonography-were perfomed. Rupture of membranes was diagnosed if any two of the standard tests were positive. Fetal fibronectin in posterior vaginal fornix was determined qualitatively by ROM kit (Adeza Biochemical, Sunnyvale, USA). RESULTS: The sensitivity of fetal fibronectin for prediction of rupture of membranes in the women who complained of fluid leakage was 90.6% and its specificity, positive and negative predictive value were 65.7%, 76.4% and 85.1% respectively. 12 women were not diagnosed as rupture of membrane on standard tests but were positive for fetal fironectin. CONCLUSION: Fetal fibronectin would be a useful diagnotic method for rupture of membranes, especially in the women who complained of fluid leakage but not diagnosed by standard tests.
Female
;
Fibronectins*
;
Humans
;
Membranes*
;
Rupture
;
Sensitivity and Specificity
5.Telemedicine in Long-Term Care: An Example of a Nursing Home System.
Jung Yong PARK ; Jeanette M DALY ; Gerald J JOGERST
Journal of the Korean Academy of Family Medicine 2002;23(9):1090-1097
No abstract available.
Long-Term Care*
;
Nursing Homes*
;
Nursing*
;
Telemedicine*
6.Prognostic Factors of Stage II Rectal Cancer.
In J PARK ; Hee C KIM ; Tae W KIM ; Jong H KIM ; Jung S KIM ; Jung R KIM ; Chang S YU ; Jin C KIM
The Korean Journal of Gastroenterology 2004;43(1):23-28
BACKGROUND/AIMS: We aimed to verify the prognostic factors of stage II rectal cancer and the effect of radiation therapy on the survival and local recurrence rate. METHODS: This study was undertaken in 202 patients who underwent curative resection of rectal cancer and confirmed to be stage II between July 1989 and December 1996. Univariate and multivariate (Cox's model) analyses of survival were employed to identify prognostic factors. Statistical significance was assigned by p value of <0.05. RESULTS: Overall recurrence occurred in 32 patients. Four patterns of recurrence were observed: hematogenous recurrence in 17 patients, local recurrence in 11, peritoneal seeding in two and simultaneous hematogenous and local recurrence in two cases. Overall 5-year survival rate was 85.6% and 5 year disease free survival rate was 82.8%. There was no significant difference in local recurrence rate and survival according to radiation therapy or location of cancer. In multivariate analysis, the number of harvested lymph node was only a prognostic factor. CONCLUSIONS: The number of harvested lymph nodes has prognostic value in stage II rectal cancer. Postoperative radiation therapy should be considered for stage II rectal cancer with poor prognostic factors although radiation did not decrease local recurrence rate in present study.
Adolescent
;
Adult
;
Aged
;
Child
;
English Abstract
;
Female
;
Humans
;
Male
;
Middle Aged
;
Neoplasm Metastasis
;
Neoplasm Recurrence, Local
;
Prognosis
;
Rectal Neoplasms/pathology/*surgery
7.The Effect of Combination Treatment with Oral Etretinate (Ro 10 - 9359) and Vitamin E on Psoriasis Vulgaris.
Sung Nack LEE ; Jung Bock LEE ; Chung Koo CHO ; Hae Eul LEE ; Soo Chan KIM ; Duck Hyun KIM ; Dong Sik BANG ; Seung Hun LEE ; Han Sung PARK ; Hong Il KOOK ; K B MYUNG ; C J KOH ; S I CHUN ; H J KIM ; D H KIM ; J H KIM
Korean Journal of Dermatology 1984;22(2):148-154
Etretinate(Ro 10-9359), an aromatic analogue of vitamin A acid, has been known to be effective in the treatment of psoriasis, Darier's disease, pityriasis rubra pilaris, ichthyosis, and palmoplantar keratoderma when administered orally. In this experiment, we compared the therapeutic and side effects between a group with high dose therapy(initially 75mg of etretinate a day) and an another group with low dose therapy(initially 40mg of etretinate a day). We also observed whether the pretreatment followed by combined treatment with vitamin E could potentiate the therapeutic effect as well as reduce the side effects of oral etretinate. This experiment comprised 102 moderate to severe psoriatic patients. The following results were obtained from this experiment. 1. Fifty-six among 92 patients(61%) who were treated with etretinate for more than 4 weeks showed good to excellent therapeutic effect. 2 The high dose therapy was more effective, but showed more side effects than low dose therapy. 3 Vitamin E did not potentiate the effect of etretinate. In low dose therapy, the pretreatment followed by combined treatment with vitamin E showed a tendency to reduce the side effects of etretinate.
Acitretin*
;
Darier Disease
;
Etretinate*
;
Humans
;
Ichthyosis
;
Keratoderma, Palmoplantar
;
Pityriasis Rubra Pilaris
;
Psoriasis*
;
Tretinoin
;
Vitamin E*
;
Vitamins*
8.Risk Factors for Aseptic Meningitis in Herpes Zoster Patients.
Sang Hoon KIM ; Seong Min CHOI ; Byeong C KIM ; Kang Ho CHOI ; Tai Seung NAM ; Joon Tae KIM ; Seung Han LEE ; Man Seok PARK ; Seong J KIM
Annals of Dermatology 2017;29(3):283-287
BACKGROUND: Herpes zoster (HZ) is caused by reactivation of latent varicella-zoster virus (VZV) infection. HZ-associated aseptic meningitis, a rare complication of HZ, can require hospitalization and a long treatment period. OBJECTIVE: A retrospective study was performed to identify potential factors associated with HZ-associated aseptic meningitis development. METHODS: We included all outpatients and patients admitted in the neurology and dermatology departments of a single tertiary center, who were diagnosed with HZ for two years. Among 818 patients, 578 patients were eligible for analysis. RESULTS: The demographics and potential risk factors were compared between the uncomplicated HZ group (n=554) and aseptic meningitis group (n=24). Among the potential factors, the dermatological distribution of skin rash and gender showed statistically significantly different between the two groups. Patients with craniocervical distribution of HZ accounted for 87.5% (n=21) of the aseptic meningitis group and 54.3% (n=301) of the uncomplicated HZ group (p=0.043). The aseptic meningitis group had more men (66.7%, n=16) than the uncomplicated HZ group (42.8%, n=237, p=0.033). Patients with craniocervical distribution had an odds ratio (OR) of 5.884 (p=0.001) for developing aseptic meningitis when compared with the other dermatome involvements. Additional logistic regression analysis resulted in a fading between gender difference (p=0.050) and craniocervical involvement having an OR of 5.667 for aseptic meningitis (p=0.006). CONCLUSION: In HZ patients, skin rash with craniocervical distribution and male gender were associated with a higher risk of aseptic meningitis.
Demography
;
Dermatology
;
Exanthema
;
Herpes Zoster*
;
Herpesvirus 3, Human
;
Hospitalization
;
Humans
;
Logistic Models
;
Male
;
Meningitis
;
Meningitis, Aseptic*
;
Neurology
;
Odds Ratio
;
Outpatients
;
Retrospective Studies
;
Risk Factors*
9.Neuropsychological and Neuroimaging Findings of Semantic Dementia.
Jay C KWON ; Sue J KANG ; Ju Hee CHIN ; Yeon Wook KANG ; Young Mi LEE ; Hyang Hee KIM ; Jung Mi PARK ; Sang Eun KIM ; Duk L NA
Journal of the Korean Neurological Association 2001;19(6):598-607
BACKGROUND: Semantic dementia (SD) is a temporal variant of frontotemporal lobar degeneration (FTLD), which is characterized by naming difficulty, decreased comprehension of words, prosopagnosia and object visual agnosia. We report clinical features, neuropsychological and neuroimaging findings of 4 patients with SD. METHODS: Of 55 patients diagnosed as having FTLD between Jan 1995 and May 2001 at Samsung Medical Center, four patients fulfilled the diagnostic criteria of SD proposed by consensus on FTLD diagnostic criteria. We investigated their clinical features such as presenting symptoms and abnormal behaviors, neuropsychological and neuroimaging findings. Neuropsychological tests included the Seoul Neuropsychological Screening Battery, the Korean-version of Western Aphasia Battery and Hanja reading and writing. All patients underwent brain MRI and FDG-PET. RESULTS: All of the patients showed naming difficulty as a presenting symptom. Language assessments showed severe naming and compre-hension difficulties with preserved fluency and repetition, which were compatible with transcortical sensory aphasia. Whereas Hangul reading aloud and writing were intact, three patients were impaired at Hanja reading and writing. Other neuropsychological tests were remarkable for prosopagnosia, object visual agnosia and memory loss. Brain MRI showed asymmetric temporal atrophies, mainly left antero-inferior temporal cortices. FDG-PET also showed hypome-tabolism in bilateral anterior temporal lobes, more severe on the left. CONCLUSIONS: Our SD patients had characteristic neuropsychological and neuroimaging findings, which can be differentiated from other neurodegenerative diseases. We also found Hanja alexia and agraphia in SD patients, which has not been reported yet.
Agnosia
;
Agraphia
;
Aphasia
;
Aphasia, Wernicke
;
Atrophy
;
Brain
;
Comprehension
;
Consensus
;
Dyslexia
;
Frontotemporal Dementia*
;
Frontotemporal Lobar Degeneration
;
Humans
;
Magnetic Resonance Imaging
;
Mass Screening
;
Memory Disorders
;
Neurodegenerative Diseases
;
Neuroimaging*
;
Neuropsychological Tests
;
Prosopagnosia
;
Semantics*
;
Seoul
;
Temporal Lobe
;
Writing
10.ER71/ETV2 Promotes Hair Regeneration from Chemotherapeutic Drug-Induced Hair Loss by Enhancing Angiogenesis
Tae-Jin LEE ; Hee-Kyoung KANG ; Jeffrey C. BERRY ; Hong-Gu JOO ; Changwon PARK ; Mark J. MILLER ; Kyunghee CHOI
Biomolecules & Therapeutics 2021;29(5):545-550
Chemotherapy-induced alopecia and hair loss can be stressful in patients with cancer. The hair grows back, but sometimes the hair tends to stay thin. Therefore, understanding mechanisms regulating hair regeneration may improve the management of chemotherapy-induced alopecia. Previous studies have revealed that chemotherapeutic agents induce a hair follicle vascular injury. As hair growth is associated with micro-vessel regeneration, we postulated that the stimulation of angiogenesis might enhance hair regeneration. In particular, mice treated with 5-fluorouracil (5-FU) showed delayed anagen initiation and reduced capillary density when compared with untreated controls, suggesting that the retardation of anagen initiation by 5-FU treatment may be attributed to the loss of perifollicular micro-vessels. We investigated whether the ETS transcription factor ETV2 (aka ER71), critical for vascular development and regeneration, can promote angiogenesis and hair regrowth in a 5-FU-induced alopecia mouse model. Tie2-Cre; Etv2 conditional knockout (CKO) mice, which lack Etv2 in endothelial cells, presented similar hair regrowth rates as the control mice after depilation. Following 5-FU treatment, Tie2-Cre; Etv2 CKO mice revealed a significant reduction in capillary density, anagen induction, and hair restoration when compared with controls. Mice receiving lentiviral Etv2 injection after 5-FU treatment showed significantly improved anagen induction and hair regrowth. Two-photon laser scanning microscopy revealed that enforced Etv2 expression restored normal vessel morphology after 5-FU mediated vessel injury. Our data suggest that vessel regeneration strategies may improve hair regrowth after chemotherapeutic treatment.